Sort
53,477 grants matching “addiction”
Telemedicine for Treatment of Opioid Use Disorder
$756,872Haiden A. Huskamp · Harvard Medical School · R01 · FY2020 · DA
Funding for MTA study (NIMH) - Duke
$756,423Karen Wells · Duke University · N01 · FY2010 · DA
Drosophila Genomics Resource Center
$756,364Justen R Andrews · Trustees Of Indiana University · P40 · FY2011 · RR
Drosophila Genomics Resource Center
$756,364Peter T Cherbas · Trustees Of Indiana University · P40 · FY2012 · OD
Collaborative Research: SCH: Psychophysiological Sensing to Enhance Mindfulness-Based Interventions for Self-Regulation of Opioid Cravings
$756,356Asif Salekin · Syracuse University · · FY2022 · CSE
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network
$756,329T John Winhusen · University Of Cincinnati · UG1 · FY2017 · DA
Development of Selective Inhibitors of NaV1.7 as Therapeutics for Pain
$756,321John Vincent Mulcahy · Siteone Therapeutics, Inc. · R44 · FY2015 · NS
Novel approach for developing antibody reagents to probe changes in the synapse p
$756,189Xiaomin Fan · Avantgen, Inc. · R44 · FY2015 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$756,158James L. Sorensen · University Of California, San Francisco · UG1 · FY2015 · DA
Substance Disorders, Substance Use Treatment, and Sexual Orientation in Youth
$756,071Heather L. Corliss · Brigham And Women'S Hospital · R01 · FY2014 · DA
NEW STRATEGIES FOR ANTICOCAINE MEDICATIONS
$756,062Mc Lean Hospital (Belmont, Ma) · U19 · FY2000 · DA
Abstinence-Contingent Wage Supplements for Long-Term Treatment of Drug Addiction
$756,002Kenneth Silverman · Johns Hopkins University · R01 · FY2015 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$755,924Philip Todd Korthuis · Oregon Health & Science University · UG1 · FY2021 · DA
Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use and Chronic Pain Management
$755,911Nina Cooperman · Rbhs-Robert Wood Johnson Medical School · R33 · FY2019 · AT
Imaging Brain Signal Transduction In Vivo With Radiolabeled Arachidonic Acid
$755,856Stanley I Rapoport · Aging · Z01 · FY2007 · AG
Genetic Control of Addiction by Host and Microbiome
$755,605Jason A Bubier · Jackson Laboratory · U01 · FY2022 · DA
A Type I Hybrid Effectiveness-Implementation Trial of "Mothering from the Inside Out" (MIO)
$755,576Elizabeth Peacock-Chambers · Baystate Medical Center, Inc. · R01 · FY2024 · DA
(Epi)genetic Risk Architectures in Opioid Dependent Brain
$755,523Peter Christopher Scacheri · Case Western Reserve University · R01 · FY2020 · DA
Biased Kappa Opioid Agonists as Non-addictive Analgesics
$755,423Thomas J Martin · Wake Forest University Health Sciences · R01 · FY2020 · DA
Discovery of Addiction-Related Genes with Advanced Mouse Resources
$755,409Elissa J Chesler · Jackson Laboratory · R01 · FY2018 · DA
The circadian rhythm as a lentiviral vector restriction factor
$755,206Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation
$755,200Jaimee Heffner · Fred Hutchinson Cancer Center · UG3 · FY2023 · DA
Southern Consortium Node of the Clinical Trials Network
$755,000Kelly S. Barth · Medical University Of South Carolina · UG1 · FY2025 · DA
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
$754,962Sara Becker · Brown University · R01 · FY2019 · DA
Project 1: The effects of cigarette package color on smoking behavior, exposure and risk perception when using low nicotine content cigarettes
$754,955Andrew Strasser · University Of Pennsylvania · U54 · FY2020 · CA